Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Opioid Tolerance Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Opioid Tolerance Treatmentmarket, defines the market attractiveness level of Opioid Tolerance Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Opioid Tolerance Treatment industry, describes the types of Opioid Tolerance Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Opioid Tolerance Treatment market and the development prospects and opportunities of Opioid Tolerance Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Opioid Tolerance Treatment market in Chapter 13.
By Player:
Johnson & Johnson Services
Zydus Cadila
Boehringer Ingelheim International
Otsuka Pharmaceutical
Aurobindo Pharma
Mylan
GlaxoSmithKline
Pfizer
Teva Pharmaceutical Industries
Acorda Therapeutics
By Type:
NMDA Antagonists
Alpha2-Adrenoceptor Agonists
By End-User:
Hospitals and Ambulatory Surgery Centers
Rehabilitation Centers
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Opioid Tolerance Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Opioid Tolerance Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Opioid Tolerance Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Opioid Tolerance Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Opioid Tolerance Treatment Market Analysis and Outlook to 2022
-
7.1 Global Opioid Tolerance Treatment Consumption (2017-2022)
-
7.2 United States Opioid Tolerance Treatment Consumption (2017-2022)
-
7.3 Europe Opioid Tolerance Treatment Consumption (2017-2022)
-
7.4 China Opioid Tolerance Treatment Consumption (2017-2022)
-
7.5 Japan Opioid Tolerance Treatment Consumption (2017-2022)
-
7.6 India Opioid Tolerance Treatment Consumption (2017-2022)
-
7.7 South Korea Opioid Tolerance Treatment Consumption (2017-2022)
8 Region and Country-wise Opioid Tolerance Treatment Market Analysis and Outlook to 2028
-
8.1 Global Opioid Tolerance Treatment Consumption Forecast (2022-2028)
-
8.2 United States Opioid Tolerance Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Opioid Tolerance Treatment Consumption Forecast (2022-2028)
-
8.4 China Opioid Tolerance Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Opioid Tolerance Treatment Consumption Forecast (2022-2028)
-
8.6 India Opioid Tolerance Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Opioid Tolerance Treatment Consumption Forecast (2022-2028)
9 Global Opioid Tolerance Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Opioid Tolerance Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global NMDA Antagonists Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Alpha2-Adrenoceptor Agonists Consumption and Growth Rate (2017-2022)
-
9.2 Global Opioid Tolerance Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals and Ambulatory Surgery Centers Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Rehabilitation Centers Consumption and Growth Rate (2017-2022)
10 Global Opioid Tolerance Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Opioid Tolerance Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global NMDA Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Alpha2-Adrenoceptor Agonists Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Opioid Tolerance Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals and Ambulatory Surgery Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Rehabilitation Centers Consumption Forecast and Growth Rate (2022-2028)
11 Global Opioid Tolerance Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Opioid Tolerance Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Opioid Tolerance Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Opioid Tolerance Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Opioid Tolerance Treatment Market Competitive Analysis
-
14.1 Johnson & Johnson Services
-
14.1.1 Johnson & Johnson Services Company Details
-
14.1.2 Johnson & Johnson Services Opioid Tolerance Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Johnson & Johnson Services Opioid Tolerance Treatment Product and Service
-
14.2 Zydus Cadila
-
14.2.1 Zydus Cadila Company Details
-
14.2.2 Zydus Cadila Opioid Tolerance Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Zydus Cadila Opioid Tolerance Treatment Product and Service
-
14.3 Boehringer Ingelheim International
-
14.3.1 Boehringer Ingelheim International Company Details
-
14.3.2 Boehringer Ingelheim International Opioid Tolerance Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Boehringer Ingelheim International Opioid Tolerance Treatment Product and Service
-
14.4 Otsuka Pharmaceutical
-
14.4.1 Otsuka Pharmaceutical Company Details
-
14.4.2 Otsuka Pharmaceutical Opioid Tolerance Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Otsuka Pharmaceutical Opioid Tolerance Treatment Product and Service
-
14.5 Aurobindo Pharma
-
14.5.1 Aurobindo Pharma Company Details
-
14.5.2 Aurobindo Pharma Opioid Tolerance Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Aurobindo Pharma Opioid Tolerance Treatment Product and Service
-
14.6 Mylan
-
14.6.1 Mylan Company Details
-
14.6.2 Mylan Opioid Tolerance Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Mylan Opioid Tolerance Treatment Product and Service
-
14.7 GlaxoSmithKline
-
14.7.1 GlaxoSmithKline Company Details
-
14.7.2 GlaxoSmithKline Opioid Tolerance Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 GlaxoSmithKline Opioid Tolerance Treatment Product and Service
-
14.8 Pfizer
-
14.8.1 Pfizer Company Details
-
14.8.2 Pfizer Opioid Tolerance Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Pfizer Opioid Tolerance Treatment Product and Service
-
14.9 Teva Pharmaceutical Industries
-
14.9.1 Teva Pharmaceutical Industries Company Details
-
14.9.2 Teva Pharmaceutical Industries Opioid Tolerance Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Teva Pharmaceutical Industries Opioid Tolerance Treatment Product and Service
-
14.10 Acorda Therapeutics
-
14.10.1 Acorda Therapeutics Company Details
-
14.10.2 Acorda Therapeutics Opioid Tolerance Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Acorda Therapeutics Opioid Tolerance Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Opioid Tolerance Treatment
-
Figure Opioid Tolerance Treatment Picture
-
Table Global Opioid Tolerance Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Opioid Tolerance Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Opioid Tolerance Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Opioid Tolerance Treatment Consumption by Country (2017-2022)
-
Figure United States Opioid Tolerance Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Opioid Tolerance Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Opioid Tolerance Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Opioid Tolerance Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Opioid Tolerance Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Opioid Tolerance Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Opioid Tolerance Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Opioid Tolerance Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Opioid Tolerance Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Opioid Tolerance Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Opioid Tolerance Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Opioid Tolerance Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Opioid Tolerance Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NMDA Antagonists Consumption and Growth Rate (2017-2022)
-
Figure Global Alpha2-Adrenoceptor Agonists Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals and Ambulatory Surgery Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Rehabilitation Centers Consumption and Growth Rate (2017-2022)
-
Figure Global NMDA Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Alpha2-Adrenoceptor Agonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals and Ambulatory Surgery Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rehabilitation Centers Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Opioid Tolerance Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Opioid Tolerance Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table Johnson & Johnson Services (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Services Opioid Tolerance Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Services Opioid Tolerance Treatment Product and Service
-
Table Zydus Cadila (Foundation Year, Company Profile and etc.)
-
Table Zydus Cadila Opioid Tolerance Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zydus Cadila Opioid Tolerance Treatment Product and Service
-
Table Boehringer Ingelheim International (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim International Opioid Tolerance Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim International Opioid Tolerance Treatment Product and Service
-
Table Otsuka Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Otsuka Pharmaceutical Opioid Tolerance Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Otsuka Pharmaceutical Opioid Tolerance Treatment Product and Service
-
Table Aurobindo Pharma (Foundation Year, Company Profile and etc.)
-
Table Aurobindo Pharma Opioid Tolerance Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aurobindo Pharma Opioid Tolerance Treatment Product and Service
-
Table Mylan (Foundation Year, Company Profile and etc.)
-
Table Mylan Opioid Tolerance Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Opioid Tolerance Treatment Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Opioid Tolerance Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Opioid Tolerance Treatment Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Opioid Tolerance Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Opioid Tolerance Treatment Product and Service
-
Table Teva Pharmaceutical Industries (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Opioid Tolerance Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Opioid Tolerance Treatment Product and Service
-
Table Acorda Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Acorda Therapeutics Opioid Tolerance Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Acorda Therapeutics Opioid Tolerance Treatment Product and Service
-
